Share Name Share Symbol Market Type Share ISIN Share Description
Silence Therapeutics Plc LSE:SLN London Ordinary Share GB00B9GTXM62 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +16.00p +6.67% 256.00p 252.00p 256.00p 256.00p 240.00p 240.00p 589,129 16:35:15
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -20.5 -26.2 - 200

Silence Therapeutics Share Discussion Threads

Showing 50526 to 50548 of 50825 messages
Chat Pages: 2033  2032  2031  2030  2029  2028  2027  2026  2025  2024  2023  2022  Older
DateSubjectAuthorDiscuss
03/5/2019
15:06
Have we been pumped somewhere and are now being dumped?
1gw
02/5/2019
10:30
Back to hunter gathering for me
volsung
01/5/2019
11:48
Seems to be a decent bit of volume behind the recent rises. Hopefully the share price should break the 200 day ema soon. Last time it did that was last Sept.
volsung
26/4/2019
08:15
Onwards and upwards (again). Great while it lasts and long may it continue.
1gw
25/4/2019
18:34
Well I did wonder if possibly someone was buying on the expectation of good news from the Quark phase 3 results, but they seem if anything rather delayed - the old SLN management seemed to be indicating fairly early in 1Q for results, iirc. And there seems to be very little happening on the Quark "News" site. Has anyone seen anything recently about when results of the study might be released?
1gw
25/4/2019
17:53
Poss reasons for rise 1.good New management team, ,2 Quirk results soon on lead product (SLN will receive royalty if successful ,and it's products verified) 3 AS Ft article said Sunday ,similar company in USA valued at .1.6 billion ! Sln mk cap 50million ( not the 100m shown on ADVFN ?)
tarlok
25/4/2019
16:49
My solitude on the island has been disturbed...perhaps forever.
volsung
25/4/2019
16:29
Chairman announcement
viku111
25/4/2019
16:24
This spike is wonderful to see but as inexplicable (to me) as most of the crash that preceded it, with the exception of a bit of deserved punishment for (1) apparently caving on the patent dispute and (2) the musical chairs in the C-Suite. Anyone got a convincing reason for the move up other than 1 or more buyers deciding to accumulate a bit on the back of the new management team and a feeling that it was oversold?
1gw
25/4/2019
12:33
This company is finally going places.
hsm12
25/4/2019
12:20
Not sure what's up, saw Ian Ross is back so that's good news in my book. I've been holding since he took over in 2005. I only cast a glance every now and then to see if I've cracked it yet (I'll be to old soon to enjoy it if it ever blows) GLA and hi to all my old sparring partners who stayed in. ?
ukeagle2aus
24/4/2019
14:52
This and MTPH. What a day!
volsung
24/4/2019
14:49
Nice move. A very decent bounce off the lows now.
1gw
24/4/2019
07:47
So we see how much notice the MM make of FT news article on SLN , price change of 1p
tarlok
22/4/2019
20:22
No mention of the patent nonsense in the ft article. I wonder what actually happened for the management to simultaneously bail & the new lot to make almost no reference to patent disputes - except to fold.Perhaps they'd already filled their boots with arrowhead and no longer cared about sln .....
djnzloop
22/4/2019
16:32
‘After years of disappointment with get rich quick schemes I know I’m gonna get rich with this scheme. And quick!’
volsung
22/4/2019
16:28
lol. My 1st post here was 2009. Been in and out and currently out. Years of chasing a price down has rarely led anyone to riches.
waterloo01
22/4/2019
16:23
PS key part being " He (Dr David Horn Solomon, chief executive ) evidently hopes to emulate the clinical success of Arrowhead, which signed a deal late last year with Johnson & Johnson to develop and market its hepatitis B treatment. J&J also took a stake in Arrowhead and has agreed to collaborate on other drugs. Sadly, Silence sold its stake a year before at an average of $3.6 a share. Arrowhead’s shares have risen sixfold to $18-plus since the start of 2018 and are now worth more than $1.7bn. Thats for the long term
tarlok
22/4/2019
16:17
Still , the article is only stating the obvious , yes it has changed its management , yes it does burn money , yes it is still in early development , and yes bears ....in the woods lol bio stocks are brought for the long term,not just the weekend.
tarlok
22/4/2019
11:40
Not according to the FT. Story today 'revamp at Silence does little to improve investor wellbeing'
waterloo01
22/4/2019
10:42
I am walking on the beach collecting sticks. Soon I will not have to as I will be fabulously rich with my SLN shares although I will have to find a way off the island
volsung
16/4/2019
07:49
Great appointment, now sln gets serious
tarlok
14/4/2019
08:22
Well researched and good item found on BBC , nice to know we are in the the right place
tarlok
Chat Pages: 2033  2032  2031  2030  2029  2028  2027  2026  2025  2024  2023  2022  Older
Your Recent History
LSE
SLN
Silence Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191019 22:12:23